Publication: Immunotherapy in the Precision Medicine Era: Melanoma and Beyond
Loading...
Open/View Files
Date
2016
Authors
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
Public Library of Science
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Su, Mack Y., and David E. Fisher. 2016. “Immunotherapy in the Precision Medicine Era: Melanoma and Beyond.” PLoS Medicine 13 (12): e1002196. doi:10.1371/journal.pmed.1002196. http://dx.doi.org/10.1371/journal.pmed.1002196.
Abstract
In a Perspective, Mack Su and David Fisher discuss the development of immunotherapies for treatment of melanoma and other cancer types.
Description
Other Available Sources
Research Data
Keywords
Medicine and Health Sciences, Oncology, Cancer Treatment, Cancer Immunotherapy, Clinical Medicine, Clinical Immunology, Immunotherapy, Biology and Life Sciences, Immunology, Immune Response, Cell Biology, Cellular Types, Animal Cells, Blood Cells, White Blood Cells, T Cells, Immune Cells, Cancers and Neoplasms, Melanomas, Immune System Proteins, Immune Receptors, T Cell Receptors, Biochemistry, Proteins, Signal Transduction, Clinical Genetics, Personalized Medicine, Precision Medicine, Basic Cancer Research, Cancer Genomics, Genetics, Genomics, Genomic Medicine
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service